輸入代號或公司名稱後按 Enter
MASS

908 Devices Inc.

+1.18 (+11.90%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 工業應用與服務 · Laboratory Analytical Instruments
11.10USD365K成交股數459M市值本益比(近四季)7.5股價營收比+23.3%營收年增(近四季)2026-11-10下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收16.1M+36%13.4M-7%14.0M-4%13.0M+14%11.8M+59%14.3M+0%14.5M+20%11.5M+21%7.4M14.3M12.1M9.5M
營業成本7.7M6.5M6.7M6.7M6.2M7.7M6.7M5.3M3.5M6.4M6.3M5.1M
毛利8.3M+51%6.9M+3%7.4M-5%6.4M+3%5.5M+43%6.7M-15%7.8M+34%6.2M+41%3.9M7.9M5.8M4.4M
毛利率51.9%51.4%52.5%48.9%47.0%46.5%53.6%53.8%52.4%55.0%47.9%46.2%
研發費用3.6M3.5M3.8M4.4M3.8M3.9M4.2M3.6M3.3M5.5M5.5M5.4M
銷售管理費用11.1M9.9M9.1M10.3M10.2M10.5M9.7M11.1M8.2M11.3M11.2M12.0M
營業利益−12.8M+16%−12.9M-23%−16.3M-33%−15.2M+78%−11.0M+45%−16.7M+84%−24.5M+124%−8.5M-34%−7.6M−9.1M−10.9M−13.0M
營業利益率-79.7%-96.3%-116.6%-116.3%-93.6%-116.8%-168.7%-74.5%-102.5%-63.6%-90.4%-137.2%
稅後淨利−11.9M-127%−12.0M-39%−15.0M-49%−13.3M+6%43.6M-499%−19.4M+174%−29.3M+213%−12.5M+0%−10.9M−7.1M−9.3M−12.5M
淨利率-74.0%-89.3%-107.0%-102.1%370.2%-135.6%-201.8%-109.5%-147.1%-49.6%-77.3%-132.1%
稀釋 EPS-0.32-126%-0.32-45%-0.41-51%-0.370%1.23-473%-0.58+164%-0.84+190%-0.37-5%-0.33-0.22-0.29-0.39
稀釋股數37.7M36.8M36.1M35.9M35.4M34.1M34.7M34.1M32.7M32.3M32.2M32.0M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金63.0M67.6M62.8M61.8M79.2M44.0M45.0M46.8M105M118M133M161M
應收帳款11.7M9.9M11.0M6.2M6.9M8.9M16.7M11.0M7.5M12.9M10.3M8.2M
存貨14.4M13.2M15.3M15.5M12.7M10.9M17.8M18.6M16.4M15.9M14.1M13.4M
總資產198M187M191M192M196M159M178M209M190M208M211M218M
有息負債
總負債70.8M52.5M54.6M42.9M36.6M44.9M47.2M52.4M32.9M38.5M36.4M37.8M
股東權益127M134M136M149M159M115M131M156M157M170M174M181M
負債比35.8%28.1%28.6%22.4%18.7%28.1%26.5%25.1%17.3%18.5%17.3%17.3%
淨現金(現金 − 有息負債)

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流1.2M−15.0M+61%−9.4M−10.6M
資本支出40K159K903K1.2M
自由現金流1.2M−15.2M+48%−10.3M−11.8M
折舊攤銷1.1M1.3M1.3M634K
買回庫藏股
現金股利
自由現金流率8.7%-128.9%-138.2%-124.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 56.2M
Single Reportable56.2M100.0%+17.7%
地區2025 年度 · 56.2M
美國41.2M73.4%+15.7%
歐洲中東非洲10.4M18.6%+14.2%
亞太3.0M5.3%+42.5%
Americas Other1.5M2.7%+76.7%
主要客戶2025 年度 · 56.2M
United States State And Local24.2M43.1%+38.2%
Government Authority14.5M25.9%-13.6%
Rest Of World National And Provincial Organizations14.4M25.7%+21.5%
Global Pharmaceutical Industrial And Other3.0M5.3%+98.6%
產品/服務2025 年度 · 112M
產品43.3M38.5%+21.8%
Device Sales36.7M32.6%+15.7%
Recurring19.4M17.3%+21.9%
服務12.9M11.5%+5.7%
Contract117K0.1%-11.4%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY202556.2M+17.7%19.5M34.7%0.54−24.6M
FY202447.7M-4.9%−72.2M-151.2%-2.12−30.8M
FY202350.2M+7.2%−36.4M-72.5%-1.13−27.1M
FY202246.9M+11.0%−33.6M-71.6%-1.07−23.0M
FY202142.2M+56.9%−22.2M-52.5%-0.79−29.8M
FY202026.9M−12.8M-47.7%-2.354.1M